Abstract
Summary
Liposome Microspheres are drug delivery systems that are usually composed of lipids and have a spherical or spherical morphology. These microspheres are composed of lipid bilayers or lipid solids and can hold water-soluble, lipid-soluble, or both active ingredients inside.
The global Liposome Microsphere market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Liposome Microsphere Industry Forecast” looks at past sales and reviews total world Liposome Microsphere sales in 2023, providing a comprehensive analysis by region and market sector of projected Liposome Microsphere sales for 2024 through 2030. With Liposome Microsphere sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposome Microsphere industry.
This Insight Report provides a comprehensive analysis of the global Liposome Microsphere landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposome Microsphere portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liposome Microsphere market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposome Microsphere and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposome Microsphere.
United States market for Liposome Microsphere is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Liposome Microsphere is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Liposome Microsphere is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Liposome Microsphere players cover Gilead Sciences Ltd, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposome Microsphere market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Monolayer Liposome Microsphere
Multilayer Liposome Microsphere
Others
Segmentation by Application:
Pharmaceutical
Biomedical
Cosmetics
Foodstuffs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Gilead Sciences Ltd
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Lipoid
Evonik
NOF Corporation
FormuMax Scientific, Inc.
Nanopartz Inc.
Beijing Sihuan Pharmaceutical
Nanjing Sike Medicine
Key Questions Addressed in this Report
What is the 10-year outlook for the global Liposome Microsphere market?
What factors are driving Liposome Microsphere market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liposome Microsphere market opportunities vary by end market size?
How does Liposome Microsphere break out by Type, by Application?
The global Liposome Microsphere market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Liposome Microsphere Industry Forecast” looks at past sales and reviews total world Liposome Microsphere sales in 2023, providing a comprehensive analysis by region and market sector of projected Liposome Microsphere sales for 2024 through 2030. With Liposome Microsphere sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposome Microsphere industry.
This Insight Report provides a comprehensive analysis of the global Liposome Microsphere landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposome Microsphere portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liposome Microsphere market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposome Microsphere and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposome Microsphere.
United States market for Liposome Microsphere is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Liposome Microsphere is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Liposome Microsphere is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Liposome Microsphere players cover Gilead Sciences Ltd, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposome Microsphere market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Monolayer Liposome Microsphere
Multilayer Liposome Microsphere
Others
Segmentation by Application:
Pharmaceutical
Biomedical
Cosmetics
Foodstuffs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Gilead Sciences Ltd
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Lipoid
Evonik
NOF Corporation
FormuMax Scientific, Inc.
Nanopartz Inc.
Beijing Sihuan Pharmaceutical
Nanjing Sike Medicine
Key Questions Addressed in this Report
What is the 10-year outlook for the global Liposome Microsphere market?
What factors are driving Liposome Microsphere market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liposome Microsphere market opportunities vary by end market size?
How does Liposome Microsphere break out by Type, by Application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liposome Microsphere Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Liposome Microsphere by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Liposome Microsphere by Country/Region, 2019, 2023 & 2030
2.2 Liposome Microsphere Segment by Type
2.2.1 Monolayer Liposome Microsphere
2.2.2 Multilayer Liposome Microsphere
2.2.3 Others
2.3 Liposome Microsphere Sales by Type
2.3.1 Global Liposome Microsphere Sales Market Share by Type (2019-2024)
2.3.2 Global Liposome Microsphere Revenue and Market Share by Type (2019-2024)
2.3.3 Global Liposome Microsphere Sale Price by Type (2019-2024)
2.4 Liposome Microsphere Segment by Application
2.4.1 Pharmaceutical
2.4.2 Biomedical
2.4.3 Cosmetics
2.4.4 Foodstuffs
2.4.5 Others
2.5 Liposome Microsphere Sales by Application
2.5.1 Global Liposome Microsphere Sale Market Share by Application (2019-2024)
2.5.2 Global Liposome Microsphere Revenue and Market Share by Application (2019-2024)
2.5.3 Global Liposome Microsphere Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Liposome Microsphere Breakdown Data by Company
3.1.1 Global Liposome Microsphere Annual Sales by Company (2019-2024)
3.1.2 Global Liposome Microsphere Sales Market Share by Company (2019-2024)
3.2 Global Liposome Microsphere Annual Revenue by Company (2019-2024)
3.2.1 Global Liposome Microsphere Revenue by Company (2019-2024)
3.2.2 Global Liposome Microsphere Revenue Market Share by Company (2019-2024)
3.3 Global Liposome Microsphere Sale Price by Company
3.4 Key Manufacturers Liposome Microsphere Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liposome Microsphere Product Location Distribution
3.4.2 Players Liposome Microsphere Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Liposome Microsphere by Geographic Region
4.1 World Historic Liposome Microsphere Market Size by Geographic Region (2019-2024)
4.1.1 Global Liposome Microsphere Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Liposome Microsphere Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Liposome Microsphere Market Size by Country/Region (2019-2024)
4.2.1 Global Liposome Microsphere Annual Sales by Country/Region (2019-2024)
4.2.2 Global Liposome Microsphere Annual Revenue by Country/Region (2019-2024)
4.3 Americas Liposome Microsphere Sales Growth
4.4 APAC Liposome Microsphere Sales Growth
4.5 Europe Liposome Microsphere Sales Growth
4.6 Middle East & Africa Liposome Microsphere Sales Growth
5 Americas
5.1 Americas Liposome Microsphere Sales by Country
5.1.1 Americas Liposome Microsphere Sales by Country (2019-2024)
5.1.2 Americas Liposome Microsphere Revenue by Country (2019-2024)
5.2 Americas Liposome Microsphere Sales by Type (2019-2024)
5.3 Americas Liposome Microsphere Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liposome Microsphere Sales by Region
6.1.1 APAC Liposome Microsphere Sales by Region (2019-2024)
6.1.2 APAC Liposome Microsphere Revenue by Region (2019-2024)
6.2 APAC Liposome Microsphere Sales by Type (2019-2024)
6.3 APAC Liposome Microsphere Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Liposome Microsphere by Country
7.1.1 Europe Liposome Microsphere Sales by Country (2019-2024)
7.1.2 Europe Liposome Microsphere Revenue by Country (2019-2024)
7.2 Europe Liposome Microsphere Sales by Type (2019-2024)
7.3 Europe Liposome Microsphere Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Liposome Microsphere by Country
8.1.1 Middle East & Africa Liposome Microsphere Sales by Country (2019-2024)
8.1.2 Middle East & Africa Liposome Microsphere Revenue by Country (2019-2024)
8.2 Middle East & Africa Liposome Microsphere Sales by Type (2019-2024)
8.3 Middle East & Africa Liposome Microsphere Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liposome Microsphere
10.3 Manufacturing Process Analysis of Liposome Microsphere
10.4 Industry Chain Structure of Liposome Microsphere
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liposome Microsphere Distributors
11.3 Liposome Microsphere Customer
12 World Forecast Review for Liposome Microsphere by Geographic Region
12.1 Global Liposome Microsphere Market Size Forecast by Region
12.1.1 Global Liposome Microsphere Forecast by Region (2025-2030)
12.1.2 Global Liposome Microsphere Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Liposome Microsphere Forecast by Type (2025-2030)
12.7 Global Liposome Microsphere Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Gilead Sciences Ltd
13.1.1 Gilead Sciences Ltd Company Information
13.1.2 Gilead Sciences Ltd Liposome Microsphere Product Portfolios and Specifications
13.1.3 Gilead Sciences Ltd Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Gilead Sciences Ltd Main Business Overview
13.1.5 Gilead Sciences Ltd Latest Developments
13.2 Pacira
13.2.1 Pacira Company Information
13.2.2 Pacira Liposome Microsphere Product Portfolios and Specifications
13.2.3 Pacira Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Pacira Main Business Overview
13.2.5 Pacira Latest Developments
13.3 Sun Pharmaceutical
13.3.1 Sun Pharmaceutical Company Information
13.3.2 Sun Pharmaceutical Liposome Microsphere Product Portfolios and Specifications
13.3.3 Sun Pharmaceutical Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sun Pharmaceutical Main Business Overview
13.3.5 Sun Pharmaceutical Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Liposome Microsphere Product Portfolios and Specifications
13.4.3 Johnson & Johnson Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Luye Pharma
13.5.1 Luye Pharma Company Information
13.5.2 Luye Pharma Liposome Microsphere Product Portfolios and Specifications
13.5.3 Luye Pharma Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Luye Pharma Main Business Overview
13.5.5 Luye Pharma Latest Developments
13.6 Sigma-Tau
13.6.1 Sigma-Tau Company Information
13.6.2 Sigma-Tau Liposome Microsphere Product Portfolios and Specifications
13.6.3 Sigma-Tau Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sigma-Tau Main Business Overview
13.6.5 Sigma-Tau Latest Developments
13.7 Ipsen (Onivyde)
13.7.1 Ipsen (Onivyde) Company Information
13.7.2 Ipsen (Onivyde) Liposome Microsphere Product Portfolios and Specifications
13.7.3 Ipsen (Onivyde) Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ipsen (Onivyde) Main Business Overview
13.7.5 Ipsen (Onivyde) Latest Developments
13.8 CSPC
13.8.1 CSPC Company Information
13.8.2 CSPC Liposome Microsphere Product Portfolios and Specifications
13.8.3 CSPC Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 CSPC Main Business Overview
13.8.5 CSPC Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Liposome Microsphere Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Liposome Microsphere Product Portfolios and Specifications
13.10.3 Novartis Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Fudan-Zhangjiang
13.11.1 Fudan-Zhangjiang Company Information
13.11.2 Fudan-Zhangjiang Liposome Microsphere Product Portfolios and Specifications
13.11.3 Fudan-Zhangjiang Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Fudan-Zhangjiang Main Business Overview
13.11.5 Fudan-Zhangjiang Latest Developments
13.12 Lipoid
13.12.1 Lipoid Company Information
13.12.2 Lipoid Liposome Microsphere Product Portfolios and Specifications
13.12.3 Lipoid Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Lipoid Main Business Overview
13.12.5 Lipoid Latest Developments
13.13 Evonik
13.13.1 Evonik Company Information
13.13.2 Evonik Liposome Microsphere Product Portfolios and Specifications
13.13.3 Evonik Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Evonik Main Business Overview
13.13.5 Evonik Latest Developments
13.14 NOF Corporation
13.14.1 NOF Corporation Company Information
13.14.2 NOF Corporation Liposome Microsphere Product Portfolios and Specifications
13.14.3 NOF Corporation Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 NOF Corporation Main Business Overview
13.14.5 NOF Corporation Latest Developments
13.15 FormuMax Scientific, Inc.
13.15.1 FormuMax Scientific, Inc. Company Information
13.15.2 FormuMax Scientific, Inc. Liposome Microsphere Product Portfolios and Specifications
13.15.3 FormuMax Scientific, Inc. Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 FormuMax Scientific, Inc. Main Business Overview
13.15.5 FormuMax Scientific, Inc. Latest Developments
13.16 Nanopartz Inc.
13.16.1 Nanopartz Inc. Company Information
13.16.2 Nanopartz Inc. Liposome Microsphere Product Portfolios and Specifications
13.16.3 Nanopartz Inc. Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Nanopartz Inc. Main Business Overview
13.16.5 Nanopartz Inc. Latest Developments
13.17 Beijing Sihuan Pharmaceutical
13.17.1 Beijing Sihuan Pharmaceutical Company Information
13.17.2 Beijing Sihuan Pharmaceutical Liposome Microsphere Product Portfolios and Specifications
13.17.3 Beijing Sihuan Pharmaceutical Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Beijing Sihuan Pharmaceutical Main Business Overview
13.17.5 Beijing Sihuan Pharmaceutical Latest Developments
13.18 Nanjing Sike Medicine
13.18.1 Nanjing Sike Medicine Company Information
13.18.2 Nanjing Sike Medicine Liposome Microsphere Product Portfolios and Specifications
13.18.3 Nanjing Sike Medicine Liposome Microsphere Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Nanjing Sike Medicine Main Business Overview
13.18.5 Nanjing Sike Medicine Latest Developments
14 Research Findings and Conclusion